Abbott Cardiovascular Systems, Inc.
USPTO PatentsView assignee record - 640 granted patents across 65 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Abbott ranks #707 of 49,997 tracked US assignees by granted-patent volume, with 640 patents across 65 technology areas.
- #707
- of 49,997 US assignees by volume
- Top 3%
- by Innovation Score (60.8/100)
- 16.1
- avg claims per patent
- -81%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R707 · US Corporation #707 · 640 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 640 grants
- TOP-DECILE #707/49,997
- PHOTO-FINISH Mitsubishi Materials
- CPC-WIDE A61F · 65 areas
- INNOV-STRONG 60.8/100
- CLAIMS-RICH 16.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -81% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Mitsubishi Materials Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Abbott’s 60.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Abbott
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- ConocoPhillips · near
ConocoPhillips · near
61 score
- The Government of… · near
The Government of… · near
61 score
- Abbott Cardiovascula… · this assignee
Abbott Cardiovascula… · this assignee
61 score
- Blue Yonder Group · near
Blue Yonder Group · near
61 score
- Zhejiang University… · near
Zhejiang University… · near
61 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Abbott's Innovation Score is 60.8/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Abbott?
Each dot is one of Abbott’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbott’s own 16.1 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
How Abbott's grant cadence moved
Between 2020–2024, Abbott Cardiovascular Systems, Inc. received 101 grants versus 527 in 2015–2019 (-81% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 145 grants and bottomed in 2023 at 14. Lead class A61F accounts for 60.2% of the portfolio across 65 subclasses. Volume neighbours: Palo Alto Networks, Inc. (#703) and Lincoln Global, Inc. (#711).
Abbott's three-year grant acceleration
From 2019–2021 to 2022–2024, Abbott Cardiovascular Systems, Inc. moved from 94 to 54 grants (0.57x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,511. See the growth leaderboard.
Who files at Abbott's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Palo Alto Networks
Palo Alto Networks, Inc.
646 patents
- GS Yuasa Internat…
GS Yuasa International Ltd.
645 patents
- Siemens Energy
Siemens Energy, Inc.
645 patents
- Vanderbilt Univer…
Vanderbilt University
642 patents
- Mitsubishi Materi…
Mitsubishi Materials Corporation
640 patents
- S C Johnson & SON
S. C. Johnson & SON, Inc.
640 patents
- Abbott Cardiovasc… ◀
Abbott Cardiovascular Systems, Inc.
640 patents
- MANN+Hummel
MANN+HUMMEL GmbH
639 patents
- Lincoln Global
Lincoln Global, Inc.
638 patents
What this shows Abbott holds 640 patents at rank #707, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Abbott
By rank, the assignees closest to #707 in granted patent volume.
- Palo Alto Networks, Inc. #703 · 646 patents
- GS Yuasa International Ltd. #704 · 645 patents
- Siemens Energy, Inc. #705 · 645 patents
- Vanderbilt University #706 · 642 patents
- Mitsubishi Materials Corporation #708 · 640 patents
- S. C. Johnson & SON, Inc. #709 · 640 patents
- MANN+HUMMEL GmbH #710 · 639 patents
- Lincoln Global, Inc. #711 · 638 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Abbott's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Abbott, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Abbott ranks #15 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (61 here).
Similar claim depth
Nearest assignees by average claims per patent (16.1 here).
Abbott's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
61 Top 3% higher than 97% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 145 | 22.7% |
| 2016 | 132 | 20.6% |
| 2017 | 133 | 20.8% |
| 2018 | 70 | 10.9% |
| 2019 | 47 | 7.3% |
| 2020 | 30 | 4.7% |
| 2021 | 17 | 2.7% |
| 2022 | 21 | 3.3% |
| 2023 | 14 | 2.2% |
| 2024 | 19 | 3.0% |
| 2025partial year | 12 | 1.9% |
Which technologies does Abbott Cardiovascular Systems, Inc. patent most?
Top 15 of 65 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Abbott Cardiovascular Systems, Inc.'s patent record in context - here's where to go next.
- Abbott Cardiovascular Systems, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 60.2% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #707 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Abbott Cardiovascular Systems, Inc. against Palo Alto Networks, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 60.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.